AstraZeneca says 4-drug liver cancer regimen delayed progression Against TACE alone, the regimen also showed a trend toward longer survival. AstraZeneca said no new safety findings emerged; follow-up continues.

#AZN IMFINZI® (durvalumab) + IMJUDO® (tremelimumab-actl) improves PFS in early liver cancer

www.stocktitan.net/news/AZN/imfinzi-durvalu...

UK companies in the news:

#AZN #BGFD #BHP #JEMI #MCB #MRCH #MUT #RKH #SDY #SMIN #SSE #TAN #TAVI #TIN #TRCS #WIZZ #WKS #WNX #WPM

Head to Sharesify.com for news, views and analysis

Best FTSE 350 stocks to buy in April for the next five years Understand why markets remain volatile amid geopolitical tensions and fluctuating economic signals affecting investor confidence.

We asked AI (ChatGPT, Copilot, Gemini) ‘what are best FTSE 350 stocks to buy in April for next five years’... #UKshares #AI #UKinvestors #RR $RR #AZN $AZN #REL $REL #III $III #LSEG $LSEG

sharesify.com/best-ftse-35...

Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD AstraZeneca (NYSE:AZN) reported that tozorakimab met the primary endpoint in both Phase III OBERON and TITANIA trials, reducing the annualized rate of moderate-to-severe COPD exacerbations versus placebo in former smokers and the overall population. Trials randomized 2,306 patients; dosing was 300 mg every four weeks. Tozorakimab was generally well tolerated. Additional Phase III trials PROSPERO (1,713 randomized) and MIRANDA (1,454) are ongoing with results expected in H1 2026.

#AZN Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD

www.stocktitan.net/news/AZN/tozorakimab-met...

UK companies in the news:

#AMCO #AZN #BGEU #CHAR #COIL #CTPE #FOG #GBG #GSK #HRI #IMM #MTLN #PMG #PTEC #SEE #SNRE #WKS

Head to Sharesify.com for news, views and analysis

UK companies in the news:

#ATT #AVCT #AZN #CRH #DLN #DSW #EWI #FCIT #GPE #LIO #MET1 #MSLH #MTE #RVRG #SDLF #SGRO #SMT #SRC #SRT #SYS1 #TENG #TIG #VOF

Head to Sharesify.com for news, views and analysis.

UK companies in the news:

#AAL #AML #AZN #BRSC #CHG #CHRY #DGI9 #KOS #PULS #RESI #SBTX #SEC #SGRO #TBCG #THRG #TLW

Head to Sharesify.com for news, views and analysis.

Sweden
- Mistral AI announced a ~€1.2B investment with EcoDataCenter to build AI data center capacity iBorlänge
- Berget AI raised €2.1M for a sovereign AI stack
- Swedish consortium #AZN, #ERIC, Saab, SEB + Wallenberg Investments partnered with #NVDA to build Swedish AI infrastructure capacity

AstraZeneca - Research-Based BioPharmaceutical Company AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.

#AZN 🆙+1%✅ £140.40✅
MT #AstraZeneca
✅2025 was another year of strong growth with excellent pipeline delivery across all therapy areas and major regions.

✅Learn more here about our FY 2025 results learn.az/6013h3PrH

😊I continue to hold $AZN & compounding their #dividends for 32 yrs👍

UK companies in the news today:

#ACSO #AFC #APTD #AZN #BARC #BP #BWY #CCH #DNLM #ELCO #GDP #GMR #GNIP #GSK #RFX #SDG #SUS

Head to Sharesify.com for news, views, analysis and more.

#AZN 🆙+1.8%✅ £138.50✅
I'll continue to compounding #AZN.L shares beyond 32 years👍

Today AstraZeneca begins trading on the #NYSE.
"This landmark moment makes it easier for investors to participate in our future and our ambitions to deliver innovative medicines to patients" spr.ly/6015hGnw5 $AZN

UK companies in the news:

#3IN #AEP #ATG #ATOM #AZN #BBY #BBSN #BEG #CABP #CHH #DSCV #GABI #GCP #GDP #GNS #ORIT #SSON #VARE #XPF #ZOO

Head to Sharesify.com for news, views, analysis and more.

Top global stories this week: LVMH, Puma, SoftBank among notable names The last week of January was marked by central bank decisions, corporate earnings and key economic data.The Federal Reserve kept its policy rate...

Top global stories this week: LVMH, Puma, SoftBank among notable names

#nvda #azn #sftbf #lvmhf #pmmaf #rio #anpdy #sftby #baba #stoxx #nky:ind

Origin | Interest | Match

AstraZeneca expands weight-loss portfolio with CSPC deal Pharmaceutical giant AstraZeneca (AZN) is expanding its weight-loss and diabetes drug portfolio in a deal with China’s CSPC. In total, the two firms have agreed to develop eight treatments including a...

AstraZeneca expands weight-loss portfolio with CSPC deal.

#AZN $AZN

sharesify.com/is-expanding...

UK companies in the news:

#AAF #AVON #AZN #CAU #CHRT #CHRY #CMPI #DRX #EXPN #GEM #JEMA #NOG #PEEL #RCFX #RUA #SRAD #STX #TRT #VAST #WIZZ #WKS #YCA

Head to Sharesify.com for news, views and analysis.

TROPION-Lung17 TROP2 Biomarker Directed Phase 3 Trial of DATROWAY® Initiated in Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer AstraZeneca (AZN) and Daiichi Sankyo initiated TROPION-Lung17, a phase 3 trial testing DATROWAY versus docetaxel in patients with previously treated, locally advanced or metastatic nonsquamous NSCLC that are TROP2 NMR positive. The trial prospectively enrolls patients using AstraZeneca’s Quantitative Continuous Scoring (QCS) TROP2 NMR biomarker; the investigational AI-powered companion diagnostic has received a Breakthrough Device Designation in the U.S. The first patient has been dosed, and TROPION-Lung17 is the ninth phase 3 study of DATROWAY in NSCLC.

#AZN TROPION-Lung17 TROP2 Biomarker Directed Phase 3 Trial of DATROWAY® Initiated in Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer

www.stocktitan.net/news/AZN/tropion-lung17-...

Walmart to replace AstraZeneca on Nasdaq 100 (WMT:NASDAQ) Walmart (WMT) stock joins the Nasdaq-100 on Jan. 20, 2026, replacing AstraZeneca (AZN) stock—potentially driving $19B in index-fund inflows. Read more here.

Walmart to replace AstraZeneca on Nasdaq 100 effective Jan. 20

#wmt #azn #qqq

Origin | Interest | Match

Walmart To Join Nasdaq 100 Next Week, AstraZeneca Exits

The changes will take effect before the market opens on Jan. 20. US markets will be closed on Jan. 19 for a holiday.

#WMT #AZN

DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer AstraZeneca (AZN) and collaborators have dosed the first patient in the DESTINY-Endometrial02 phase 3 trial testing ENHERTU® (trastuzumab deruxtecan) as adjuvant therapy versus standard chemotherapy, with or without radiotherapy, for patients with HER2 expressing (IHC 3+/2+) endometrial cancer.The global trial is conducted with The GOG Foundation and ENGOT (lead group GINECO). ENHERTU is co‑developed with Daiichi Sankyo. The release notes HER2 expression in ~18%–56% of endometrial cancers and a 39%–56% 18‑month recurrence/death rate in high‑risk patients after standard adjuvant care. There are currently no approved HER2 directed adjuvant therapies for this indication.

#AZN DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer

www.stocktitan.net/news/AZN/destiny-endomet...

#AZN DESTINY-Ovarian01 Phase 3 Trial of ENHERTU® Initiated as First-Line Maintenance Therapy in Patients with HER2 Expressing Advanced Ovarian Cancer

www.stocktitan.net/news/AZN/destiny-ovarian...

#AZN AstraZeneca advances hematology and cell therapy ambition with largest-ever presence at ASH

www.stocktitan.net/news/AZN/astra-zeneca-ad...

FDA Accepts AstraZeneca’s Baxdrostat for Priority Review in Resistant Hypertension AstraZeneca (NASDAQ: AZN) has received FDA Priority Review for Baxdrostat, its investigational aldosterone synthase inhibitor designed for patients with hard-to

(NASDAQ: #AZN)
#AstraZeneca's Baxdrostat was accepted for FDA Priority Review for resistant hypertension. The NDA is supported by Phase 3 data showing significant blood pressure reduction. A decision is expected by Q2 2026.
prismmarketview.com/fda-accepts-...

#IONQ #MSFT #GOOGL #AMZN #IBM #AZN #GOOG #QUBT #SSNL.F #QBTS #c5cf6f2c-46d3-4c48-9d17-3bcfcb6043b3

Origin | Interest | Match

#AZN Statistically significant NATRON Phase III trial results for hypereosinophilic syndrome show FASENRA delayed time to first flare or worsening of disease

www.stocktitan.net/news/AZN/statistically-s...

after earnings

#AZN Astrazeneca = +3.5%
#YETI Yeti = +4%
#GOOS Canada Goose = -15%
#DNUT Krispy Kreme = +10%
#UAA Under Armor = -3%
#COP ConocoPhillips = -1%
#MRNA Moderna = +4%
#WBD Warner Bros = 0%
#PZZA Papa Johns = +5%
#PENN Penn Entertainment = -5%
#NVAX Novavax = 0%

AstraZeneca reports Q3 2025 revenue of $11.6 bn and 9M revenue of $34.7 bn, up 9%. Core EPS rose 16% to $5.82, beating forecasts. Dividend set at $0.935 per share as guidance reaffirmed.

#AZN #Earnings #Pharma #Healthcare #Investing #Stocks #Money #Finance #Trending #News #Motivation #Viral #FYP

#AZN AstraZeneca's 9M and Q3 2025 Financial Results

www.stocktitan.net/news/AZN/astra-zeneca-s-...

#AZN £124
✅Books record quarterly revenue of $15B
✅ $AZN 9M total revenue up 11% to $43.2bn

MT @AstraZeneca
📈 Our 9M & Q3 results are now available and show strong momentum, with Total Revenue up 11% and excellent pipeline delivery: learn.az/601973eAt